IDO1 is expressed in tumor infiltrating T cells and its enzymatic activity converts tryptophan to kynurenine – a molecule which reduces cytotoxic T and NK cell activity, while promoting the expansion of immunosuppressive regulatory T cell and myeloid derived suppressor cell populations (125). The gene discussed is IDO1; the disease is neoplasm.